Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Invested Capital (2016 - 2026)

Insmed's Invested Capital history spans 17 years, with the latest figure at $1.3 billion for Q1 2026.

  • Quarterly Invested Capital rose 2.52% to $1.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Mar 2026, up 2.52% year-over-year, with the annual reading at $763.0 million for FY2025, 45.77% down from the prior year.
  • Invested Capital came in at $1.3 billion for Q1 2026, up from $763.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.8 billion in Q2 2025 to a low of -$302.3 million in Q4 2023.
  • The 5-year median for Invested Capital is $1.1 billion (2023), against an average of $1.0 billion.
  • Year-over-year, Invested Capital tumbled 124.34% in 2023 and then surged 565.48% in 2024.
  • Insmed's Invested Capital stood at $1.2 billion in 2022, then plummeted by 124.34% to -$302.3 million in 2023, then soared by 565.48% to $1.4 billion in 2024, then crashed by 45.77% to $763.0 million in 2025, then skyrocketed by 64.03% to $1.3 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Invested Capital are $1.3 billion (Q1 2026), $763.0 million (Q4 2025), and $1.5 billion (Q3 2025).